|
regionalization
|
GO:0003002 |
337 |
0.690
|
Zebrafish Mouse |
|
labyrinthine layer blood vessel development
|
GO:0060716 |
21 |
0.610
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.602
|
Mouse |
|
cell fate commitment
|
GO:0045165 |
210 |
0.598
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.568
|
Zebrafish Mouse |
|
axon guidance
|
GO:0007411 |
141 |
0.545
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.511
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.502
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.489
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.465
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.461
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.460
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.453
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.443
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.417
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.413
|
Zebrafish |
|
chemotaxis
|
GO:0006935 |
247 |
0.404
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.396
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.396
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.395
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
41 |
0.364
|
|
|
skin development
|
GO:0043588 |
220 |
0.361
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.360
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.353
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.344
|
|
|
appendage development
|
GO:0048736 |
166 |
0.340
|
Mouse |
|
ear development
|
GO:0043583 |
200 |
0.337
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.322
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.310
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.301
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.298
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.295
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.291
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.287
|
Mouse |
|
placenta development
|
GO:0001890 |
140 |
0.282
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.281
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.271
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.271
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.265
|
|
|
gland development
|
GO:0048732 |
330 |
0.261
|
Mouse |
|
neuron projection guidance
|
GO:0097485 |
141 |
0.260
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.259
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.253
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.251
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.248
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.243
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.240
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.233
|
Mouse |
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.232
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.231
|
Mouse |
|
odontogenesis
|
GO:0042476 |
78 |
0.225
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.222
|
Mouse |
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.212
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.204
|
|
|
limb development
|
GO:0060173 |
166 |
0.202
|
Mouse |
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.197
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.196
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.196
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.191
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.190
|
|
|
pallium development
|
GO:0021543 |
120 |
0.189
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.186
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.184
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.184
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.179
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.178
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.177
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.176
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.170
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.169
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.163
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.163
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.162
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.162
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.160
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.160
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.160
|
|
|
positive regulation of transcription via serum response element binding
|
GO:0010735 |
1 |
0.154
|
|
|
ventral spinal cord interneuron fate commitment
|
GO:0060579 |
14 |
0.153
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.153
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.148
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.148
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.147
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.145
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.145
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.144
|
|
|
segmentation
|
GO:0035282 |
93 |
0.144
|
Zebrafish |
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.140
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.139
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.138
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.137
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.137
|
Mouse |
|
striated muscle cell development
|
GO:0055002 |
125 |
0.136
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.136
|
|
|
cell fate determination
|
GO:0001709 |
32 |
0.134
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.131
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.130
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.130
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.127
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.127
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.123
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.122
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.121
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.119
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.118
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.117
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.117
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.117
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.116
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.115
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.115
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.113
|
|
|
tube closure
|
GO:0060606 |
91 |
0.112
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.111
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.110
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.108
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.107
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.106
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.105
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.105
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.104
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.104
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.102
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.102
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.102
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.101
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.101
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.101
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.100
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.100
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.099
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
37 |
0.099
|
|
|
establishment of glial blood brain barrier
|
GO:0060857 |
2 |
0.096
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.096
|
|
|
positive regulation of glial cell differentiation
|
GO:0045687 |
21 |
0.096
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.095
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.095
|
|
|
ossification
|
GO:0001503 |
216 |
0.095
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.094
|
|
|
artery development
|
GO:0060840 |
53 |
0.094
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.093
|
|
|
cation transport
|
GO:0006812 |
399 |
0.091
|
|
|
neuron fate specification
|
GO:0048665 |
30 |
0.091
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.091
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.090
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.090
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.090
|
|
|
regulation of transcription from rna polymerase ii promoter involved in determination of left right symmetry
|
GO:1900094 |
2 |
0.089
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.089
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.089
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.088
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.088
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.088
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.086
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.086
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.086
|
|
|
gonad development
|
GO:0008406 |
141 |
0.086
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.085
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.085
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.083
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.083
|
|
|
spinal cord patterning
|
GO:0021511 |
25 |
0.083
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.082
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.082
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.082
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.081
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.080
|
Zebrafish |
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.080
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.079
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.079
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.078
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.078
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.077
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.076
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.076
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.075
|
|
|
cardiac pacemaker cell fate commitment
|
GO:0060927 |
1 |
0.075
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.075
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.075
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.075
|
|
|
regulation of microvillus assembly
|
GO:0032534 |
3 |
0.074
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.073
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.073
|
Zebrafish |
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.072
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.072
|
|
|
atrial cardiac muscle cell development
|
GO:0055014 |
2 |
0.072
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.072
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.071
|
Human |
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.071
|
|
|
positive regulation of cell division
|
GO:0051781 |
31 |
0.071
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.070
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.070
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.070
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.069
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
21 |
0.069
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.069
|
|
|
nerve development
|
GO:0021675 |
67 |
0.069
|
|
|
myelination
|
GO:0042552 |
74 |
0.069
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.068
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.068
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.068
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.068
|
|
|
purkinje myocyte differentiation
|
GO:0003168 |
1 |
0.068
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.067
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.066
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.066
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.066
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.065
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.065
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.065
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.065
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.064
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.063
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.063
|
|
|
type b pancreatic cell fate commitment
|
GO:0003327 |
1 |
0.063
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.063
|
|
|
spleen development
|
GO:0048536 |
39 |
0.063
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.062
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.062
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.062
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.062
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.062
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.061
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.061
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.061
|
|
|
sprouting angiogenesis
|
GO:0002040 |
26 |
0.061
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.061
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.061
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.061
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.061
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.060
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.060
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.060
|
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.060
|
|
|
atrioventricular node cell development
|
GO:0060928 |
2 |
0.060
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.059
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.058
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.058
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
42 |
0.058
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.058
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.058
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.057
|
|
|
spinal cord dorsal ventral patterning
|
GO:0021513 |
23 |
0.057
|
|
|
cell growth
|
GO:0016049 |
130 |
0.056
|
|
|
regulation of microvillus organization
|
GO:0032530 |
3 |
0.056
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.055
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.055
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.055
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.055
|
|
|
atrial cardiac muscle cell differentiation
|
GO:0055011 |
2 |
0.054
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.054
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.054
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.054
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.053
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.053
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.052
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.052
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.052
|
|
|
mechanoreceptor differentiation
|
GO:0042490 |
67 |
0.052
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.052
|
|
|
nephron development
|
GO:0072006 |
109 |
0.051
|
|
|
neurohypophysis development
|
GO:0021985 |
2 |
0.051
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.051
|
Mouse |
|
positive regulation of auditory receptor cell differentiation
|
GO:0045609 |
1 |
0.051
|
|
|
mesodermal cell differentiation
|
GO:0048333 |
22 |
0.051
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.051
|
|
|
auditory receptor cell differentiation
|
GO:0042491 |
37 |
0.051
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.051
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.051
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.050
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.050
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.050
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.050
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.050
|
|
|
cardiac cell fate determination
|
GO:0060913 |
2 |
0.050
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.050
|
|
|
carbon catabolite repression of transcription from rna polymerase ii promoter
|
GO:0000437 |
1 |
0.050
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.049
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.049
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.049
|
|
|
renal system development
|
GO:0072001 |
225 |
0.049
|
|
|
auditory receptor cell fate specification
|
GO:0042667 |
1 |
0.049
|
|
|
lung development
|
GO:0030324 |
164 |
0.049
|
|
|
leydig cell differentiation
|
GO:0033327 |
10 |
0.048
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.048
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.048
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.047
|
|
|
regulation of timing of cell differentiation
|
GO:0048505 |
11 |
0.047
|
|
|
brain segmentation
|
GO:0035284 |
3 |
0.047
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.047
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.047
|
|
|
regulation of neuroblast proliferation
|
GO:1902692 |
27 |
0.046
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.046
|
|
|
motor neuron axon guidance
|
GO:0008045 |
26 |
0.046
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.046
|
|
|
metanephric nephron development
|
GO:0072210 |
34 |
0.046
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.046
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.046
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.045
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.045
|
|
|
cardiac neural crest cell migration involved in outflow tract morphogenesis
|
GO:0003253 |
3 |
0.045
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.045
|
|
|
cell fate commitment involved in formation of primary germ layer
|
GO:0060795 |
26 |
0.045
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.044
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.044
|
|
|
regulation of muscle cell apoptotic process
|
GO:0010660 |
17 |
0.044
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.044
|
|
|
glial cell fate commitment
|
GO:0021781 |
14 |
0.044
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.044
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.044
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.044
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.044
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.044
|
|
|
nephrogenic mesenchyme development
|
GO:0072076 |
3 |
0.043
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.043
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.043
|
|
|
hemangioblast cell differentiation
|
GO:0060217 |
1 |
0.043
|
|
|
embryonic camera type eye development
|
GO:0031076 |
36 |
0.043
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.043
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.043
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.042
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.042
|
|
|
brain morphogenesis
|
GO:0048854 |
32 |
0.042
|
Mouse |
|
ventral spinal cord interneuron fate determination
|
GO:0060580 |
1 |
0.042
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.042
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.041
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.041
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.041
|
|
|
positive regulation of inositol phosphate biosynthetic process
|
GO:0060732 |
2 |
0.041
|
|
|
ventral spinal cord interneuron differentiation
|
GO:0021514 |
16 |
0.041
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.041
|
|
|
metanephric dct cell differentiation
|
GO:0072240 |
3 |
0.041
|
|
|
nodal signaling pathway involved in determination of left right asymmetry
|
GO:0038107 |
2 |
0.041
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.041
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.040
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.040
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.040
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.040
|
|
|
regulation of organ formation
|
GO:0003156 |
34 |
0.040
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.040
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.040
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.040
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.040
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.040
|
|
|
tube formation
|
GO:0035148 |
140 |
0.040
|
|
|
spinal cord oligodendrocyte cell differentiation
|
GO:0021529 |
3 |
0.040
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.040
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.040
|
|
|
myeloid cell activation involved in immune response
|
GO:0002275 |
34 |
0.039
|
|
|
action potential
|
GO:0001508 |
78 |
0.039
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.039
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.039
|
|
|
bundle of his development
|
GO:0003166 |
4 |
0.038
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.038
|
|
|
atrioventricular node cell fate commitment
|
GO:0060929 |
1 |
0.038
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.038
|
|
|
axial mesodermal cell fate commitment
|
GO:0048322 |
1 |
0.038
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.038
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.037
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.037
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.037
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.037
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.037
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
38 |
0.037
|
|
|
midbrain development
|
GO:0030901 |
35 |
0.037
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.037
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
43 |
0.037
|
|
|
mesodermal cell fate commitment
|
GO:0001710 |
17 |
0.037
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.037
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.036
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.036
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.036
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.036
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.036
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.036
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.036
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.036
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.036
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.036
|
|
|
histone modification
|
GO:0016570 |
159 |
0.036
|
|
|
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000800 |
1 |
0.035
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.035
|
|
|
neural crest cell differentiation
|
GO:0014033 |
54 |
0.035
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.035
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.035
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.035
|
Zebrafish |
|
cellular response to antibiotic
|
GO:0071236 |
4 |
0.035
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.035
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.035
|
|
|
regulation of notch signaling pathway
|
GO:0008593 |
35 |
0.035
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.034
|
|
|
positive regulation of neuroblast proliferation
|
GO:0002052 |
19 |
0.034
|
|
|
left lung development
|
GO:0060459 |
4 |
0.034
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.034
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.034
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.034
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.034
|
|
|
ventricular cardiac muscle cell development
|
GO:0055015 |
11 |
0.034
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.034
|
|
|
nodal signaling pathway involved in determination of lateral mesoderm left right asymmetry
|
GO:1900164 |
2 |
0.034
|
|
|
left right pattern formation
|
GO:0060972 |
23 |
0.034
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.034
|
Mouse |
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.033
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.033
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.033
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.033
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.033
|
|
|
myelination in peripheral nervous system
|
GO:0022011 |
19 |
0.033
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.033
|
|
|
axial mesoderm formation
|
GO:0048320 |
3 |
0.033
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.033
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.033
|
Mouse |
|
epithelial cell migration
|
GO:0010631 |
63 |
0.033
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.033
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.033
|
|
|
pulmonary myocardium development
|
GO:0003350 |
3 |
0.033
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.033
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.033
|
|
|
adenohypophysis development
|
GO:0021984 |
14 |
0.033
|
Mouse |
|
ventral spinal cord interneuron specification
|
GO:0021521 |
11 |
0.032
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.032
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.032
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.032
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.032
|
|
|
regulation of exocytosis
|
GO:0017157 |
61 |
0.032
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.032
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.032
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.032
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.032
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.032
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.031
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.031
|
Mouse |
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.031
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.031
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.031
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.030
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.030
|
|
|
clara cell differentiation
|
GO:0060486 |
4 |
0.030
|
|
|
fertilization
|
GO:0009566 |
127 |
0.030
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.030
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.030
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.030
|
|
|
cerebral cortex neuron differentiation
|
GO:0021895 |
19 |
0.030
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.030
|
|
|
atrioventricular node cell differentiation
|
GO:0060922 |
2 |
0.030
|
|
|
cell fate commitment involved in pattern specification
|
GO:0060581 |
14 |
0.030
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.030
|
|
|
positive regulation of cardioblast differentiation
|
GO:0051891 |
3 |
0.030
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.030
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.029
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.029
|
|
|
forebrain neuron development
|
GO:0021884 |
30 |
0.029
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.029
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.029
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.029
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.029
|
|
|
his purkinje system development
|
GO:0003164 |
4 |
0.029
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.029
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.029
|
|
|
plasma cell differentiation
|
GO:0002317 |
3 |
0.029
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.029
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
42 |
0.029
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.029
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.028
|
|
|
embryonic placenta morphogenesis
|
GO:0060669 |
25 |
0.028
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.028
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.028
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.028
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.028
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.028
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.028
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.028
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.027
|
|
|
embryonic heart tube formation
|
GO:0003144 |
1 |
0.027
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.027
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.027
|
|
|
blood vessel endothelial cell migration
|
GO:0043534 |
23 |
0.027
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.027
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.027
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.027
|
|
|
septum transversum development
|
GO:0003343 |
2 |
0.027
|
|
|
positive regulation of inner ear receptor cell differentiation
|
GO:2000982 |
1 |
0.027
|
|
|
hair cell differentiation
|
GO:0035315 |
40 |
0.027
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.027
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.027
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.027
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.027
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.027
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.027
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.026
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.026
|
|
|
negative regulation of stem cell maintenance
|
GO:1902455 |
4 |
0.026
|
|
|
myeloid leukocyte mediated immunity
|
GO:0002444 |
42 |
0.026
|
|
|
positive regulation of oligodendrocyte differentiation
|
GO:0048714 |
9 |
0.026
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.026
|
|